Systematic review and meta-analysis of ivermectin for treatment of COVID-19: evidence beyond the hype.
Milena Soriano MarcolinoKarina Cardoso MeiraNathalia Sernizon GuimarãesPaula Perdigão MottaVictor Schulthais ChagasSilvana Márcia Bruschi KellesLaura Caetano de SáReginaldo Aparecido ValacioPatricia Klarmann ZiegelmannPublished in: BMC infectious diseases (2022)
The evidence suggests that ivermectin does not reduce mortality risk and the risk of mechanical ventilation requirement. Although we did not observe an increase in the risk of adverse effects, the evidence is very uncertain regarding this endpoint.